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Abstract
Background: Filamentous M13 phage extrude from infected Escherichia coli with a tip structure composed of gp7
and gp9. This tip structure is extended by the assembly of the filament composed of the major coat protein gp8.
Finally, gp3 and gp6 terminate the phage structure at the proximal end. Up to now, gp3 has been the primary
tool for phage display technology. However, gp7, gp8 and gp9 could also be used for phage display and these
phage particles should bind to two different or more surfaces when the modified coat proteins are combined.
Therefore, we tested here if the amino-terminal end of gp9 can be modified and whether the modified portion is
exposed and detectable on the M13 phage particles.
Results: The amino-terminal region of gp9 was modified by inserting short sequences that encode antigenic
epitopes. We show here that the modified gp9 proteins correctly integrate into the membrane using the
membrane insertase YidC exposing the modified epitope into the periplasm. The proteins are then efficiently
assembled onto the phage particles. Also extensions up to 36 amino acid residues at the amino-terminal end of
gp9 did not interfere with membrane integration and phage assembly. The exposure of the antigenic tags on the
phage was visualised with immunogold labelling by electron microscopy and verified by dot blotting with
antibodies to the tags.
Conclusions: Our results suggest that gp9 at the phage tip is suitable for the phage display technology. The
modified gp9 can be supplied in trans from a plasmid and fully complements M13 phage with an amber mutation
in gene 9. The modified phage tip is very well accessible to antibodies.
Background
The bacteriophage M13 is assembled during a secretion
process in the cytoplasmic membrane of Escherichia
coli. Membrane inserted phage proteins contact the sin-
gle stranded phage DNA in an helical array and pass
through the outer membrane by a porin-like structure
composed of gp4 [1]. In the inner membrane a protein
complex probably consisting of gp1, gp11 and thiore-
doxin catalyses the assembly process [2]. First, mem-
brane inserted gp7 and gp9 proteins form a tip
structure [3] that is extended by a multiple array of gp8
proteins, the major coat protein. Gp8 is synthesised as a
precursor protein, termed procoat, that is inserted into
the inner membrane by the YidC protein [4,5] and is
then processed by leader peptidase [6]. After processing,
the transmembrane coat proteins assemble into
oligomers and bind to the viral DNA forming the nas-
cent phage filament [7,8]. This filament traverses the
outer membrane through the gp4 complex [1]. Finally,
the membrane inserted gp3 and gp6 proteins are
assembled onto the extruding phage at the proximal end
of the virion terminating phage assembly.
The gp3 protein has been extensively used for the
phage display technology. Since gp3 is engaged in the
adsorption of the phage onto the host cell certain
restrictions on the infectivity of the modified phage have
to be encountered [9]. This might be different for gp9
modifications since this protein is localized at the distal
end of the filamentous phage particle. Previously, it has
been shown that gp9 is accessible in the phage particle
[3]. Therefore, gp9 might be a good target for phage dis-
play technology [10]. In addition, an attractive idea is to
have both ends supplied with functional peptide moi-
eties applicable as molecular measures or bifunctional
binders.
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sised without a signal sequence. It is thought that the
membrane-inserted protein displays its N-terminus into
the periplasm. However, the first amino-terminal 17
residues are hydrophobic and it is questionable whether
the protein spans the entire bilayer. One possibility to
explore this is to fuse hydrophilic peptides onto the N-
terminus. When these modified gp9 proteins are
inserted into the membrane their amino-terminal region
can be analysed whether they are exposed in the peri-
plasm. Therefore, we have fused short antigenic peptides
to the N-terminus of gp9 between the residues 2 and 3.
They extend the protein by 17 to 36 amino acid resi-
dues. The proteins are inserted into the membrane and
efficiently assemble onto phage progeny particles since
they can substitute for the wild-type protein. Also, the
antigenic epitopes are detectable with gold-labelled anti-
bodies by electron microscopy.
Results
Antigenic epitopes at the N-terminus of M13 gp9
To study the assembly of M13 gp9, genetic variants
w e r ec o n s t r u c t e dt h a te x t e n dt h eN - t e r m i n a lr e g i o no f
the protein with antigenic epitopes. Two antigenic pep-
tides, a 17 amino acid residues long T7-tag and a 15
residues long HA-tag were fused to the N-terminus of
gp9, respectively (Figure 1). This was performed on a
gene 9 copy on a pMS119 plasmid using a unique MunI
restriction site that was engineered between the codons
2 and 3 to generate gp9MunI. Into this site, DNA frag-
ments encoding the tag sequences were introduced. In
addition, longer fragments were introduced which
encode two copies of the antigenic tag sequences, result-
ing in additional 36 and 32 residues in pMS-g9-DT7
and pMS-g9-DHA, respectively. Then, the functionality
of the modified proteins was tested by complementation
of an M13am9 phage infection (Figure 2 and 3). E. coli
K38 bearing the corresponding plasmid was grown over-
night in LB medium and plated with top agar containing
1 mM IPTG. After solidification of the top agar 10 μL
of a phage suspension was applied on top of the agar.
Plaque formation was observed after incubation at 37°C
overnight. When the cells with pMS-g9-HA were
infected with M13am9 clear plaques with a turbid zone
were visible on the bacterial lawn (Figure 2). Whereas
no plaques appeared with the K38 cells containing the
pMS plasmid (Figure 3, panel A), pMS-g7/9 transformed
cells showed plaque formation down to the 10
5-fold
dilution step (panel B). In the absence of IPTG (panel
C) plaque formation was observed at the 10
4-fold dilu-
tion which is most likely due to a low expression or to
recombination events. When K38 cells with the pMS-
Figure 1 Variants of M13 gp9 proteins. Schematic overview of the gp9 variants used in this work. Into the wild-type a MunI restriction site
was introduced between codon 2 and 3 resulting in two additional residues in gp9MunI (A). Into this MunI site short sequences were
introduced encoding for the T7 tag in gp9-T7 (B) and for the HA tag in gp9-HA (C). In addition, a double tag was introduced into gp9
generating gp9-DT7 (D) and gp9-DHA (E), respectively. The protein sequence of each mutant is given in the single letter code.
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Page 2 of 9g9-T7 (panel D) or with pMS-g9-HA (panel E) were
used plaque formation was evident down to the 10
5-fold
dilution step. Similarly, the plasmids encoding the dou-
ble tags (panels F and G) showed efficient plaque forma-
tion, as it was observed on the plates with the
suppressor containing E. coli K37 cells (panel H). These
results suggest that the gp9 variants expressing the epi-
tope-tagged proteins are functional and allow normal
phage propagation.
Expression of the modified gp9 protein in E. coli
The plasmid-encoded gp9 variants were analysed for
expression in E. coli K38. The cells were grown at 37°C
to the early exponential phase in M9 minimal medium.
Figure 2 Plaque formation of M13am9 with gp9-HA coat
protein. E. coli K38 bearing pMS-g9-HA was mixed with LB top agar
containing 1 mM IPTG and poured on an agar plate. After
solidification, M13am9 phage was applied and incubated at 37 °C
overnight.
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Figure 3 Complementation of M13am9 infections by plasmid-expressed gp9. E. coli K38 bearing the respective plasmid was mixed with LB
top agar containing 1 mM IPTG and poured on an agar plate. After solidification, 10 μL drops of serial diluted M13am9 phage suspensions were
applied. The bacterial lawn with K38 cells bearing the empty plasmid only allowed the plaque formation of revertant phage (A). K38 cells
expressing the wild-type gp9 from the plasmid (B) showed plaque formation at the 10
5-fold dilution, similar to the suppressor cells K37 (H).
When no IPTG was added to the plate plaque formation was reduced (C). Cells expressing the modified gp9 proteins all showed efficient plaque
formation. Gp9-T7 (D), gp9-HA (E), gp9-DT7 (F) and gp9-DHA (G) were analysed.
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and after 10 min the newly synthesised proteins were
pulse-labelled for 10 min with
35S-methionine. The total
bacterial proteins were TCA precipitated to remove the
non-incorporated
35S-methionine and immunoprecipi-
tated using an antiserum to the T7 tag or to the HA
tag, respectively (Figure 4). Since gp9 is a very small
protein of 32 amino acids containing only two methio-
nines the protein band on a SDS tricine PAGE is diffi-
cult to visualise. When comparing the protein pattern of
cells expressing gp9-T7 (lane 3) with cells containing
the empty plasmid (lane 2) a protein band of about 5.5
kDa was observed. Also a weak band of gp9-HA (lane 4)
was visible on the gel. The size of the protein was esti-
mated in relation of the major coat protein gp8 shown
in lane 1. Since the 50 amino acid residues long gp8 has
a molecular weight of 5.2 kDa, the gp9-T7 with 51 resi-
dues and gp9-HA with 49 residues are proteins of very
similar molecular weight.
Membrane insertion of gp9-T7
The membrane insertion of gp9 with the N-terminal T7
tag was analysed in E. coli K38 cells bearing the pMS-
g9-T7 plasmid. The gp9-T7 protein was expressed as
described above. The cells were converted to sphero-
plasts and analysed by protease mapping (Figure 5A).
The protein immunoprecipitated with antiserum to the
T7 tag was readily digested by proteinase K added to
the outside of the spheroplasts (lane 2). This suggests
that the antigenic tag of gp9 was accessible to the pro-
tease at the periplasmic surface, whereas the cytoplasmic
GroEL protein was protected from digestion (lane 4).
Further, the periplasmic portion of the OmpA protein
was digested by the proteinase K (lane 6) confirming the
proteolytic activity.
The insertion of gp9-T7 into the membrane was then
investigated in E. coli JS7131. In these cells, the mem-
brane insertase YidC can be depleted when the cells are
grown in the presence of glucose [4]. After 2 h growth
under glucose conditions the cells were pulse-labelled
with
35S-methionine for 10 min and converted to spher-
o p l a s t s .T h ep r o t e a s em a p p i n g( F i g u r e5 B )s h o w st h a t
the YidC depleted cells did not allow the digestion of
the T7-epitope at the N-terminus of gp9 (lane 2). These
results suggest that the membrane insertion of gp9-T7
is YidC-dependent. In both cases, the integrity of the
spheroplasts was verified by the protection of GroEL
(lane 4) and the proteolytic activity was corroborated by
the accessibility of the OmpA protein (lane 6).
Assembly of gp9 variant proteins onto phage
Assembly of the plasmid-encoded variants onto phage was
first followed by dot-blot analysis of phage particles.
M13am9 infections in E. coli K38 bearing a plasmid cod-
ing for one of the gp9 variants were performed and the
progeny phage were collected and titrated. Equal amounts
of phage was applied on nitrocellulose, incubated with
antiserum to M13 gp8, to T7 tag or to the HA tag, respec-
tively. The reaction with a secondary peroxidase coupled
antibody was analysed by chemoluminescence (Figure 6).
gp8
1
pMS
2
gp9-T7
3
gp9-HA
4
Figure 4 Expression of gp9-T7 from a plasmid.E x p o n e n t i a l l y
growing E. coli K38 cells bearing a plasmid encoding M13 gp8 (lane
1), the empty pMS plasmid (lane 2), pMS-g9-T7 (lane 3) and pMS-
g9-HA (lane 4), respectively, were induced for 10 min with IPTG and
pulse-labelled with
35S-methionine for 10 min. The proteins were
precipitated with trichloroacetic acid (TCA) and immunoprecipitated
with antiserum to gp8 (lane 1), to T7 (lane 2, 3) and to HA (lane 4),
respectively. SDS tricine PAGE was used to separate the proteins
and the radioactivity was visualised by phosphorimaging.
OmpA GroEL
proteinase K - +            - +            - +  
1        2           3        4           5        6      
gp9-T7
OmpA GroEL
C ara        glc
B gp9-T7
1        2            3       4           5        6
proteinase K  - +            - +            - +  
A
Figure 5 Membrane insertion of gp9-T7 in E. coli K38 and
JS7131. Exponentially growing E. coli K38 cells (panel A) and JS7131
(panel B), respectively, containing the plasmid pMSg9-T7 were
pulse-labelled with
35S-methionine for 10 min. The cells were
converted to spheroplasts and incubated on ice for 1 h either in
the presence or absence of 0.5 mg/mL proteinase K. The samples
were immunoprecipitated with antiserum to T7 (lanes 1, 2), to
GroEL (lanes 3, 4) and to OmpA (lanes 5, 6), respectively, and
analysed on SDS PAGE and phosphorimaging. (C) The depletion of
YidC in the JS7131 cells grown in M9 medium with 0.2% glucose
(glc) was verified by Western blot using an antibody to YidC. As
control for the non-depleted conditions, the JS7131 cells were
grown in the presence of 0.2% arabinose (ara).
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anti gp8 serum (panel A), thep h a g eg r o w ni nc e l l sw i t h
pMS-g9-T7 clearly reacted with the T7 serum (panel B).
Similarly, phage from cells expressing the double tag gp9-
DT7 also reacted with the serum to the T7 tag. Strong sig-
nals were obtained with gp9 proteins with the HA epi-
topes (panel C) whereas the uninfected K38 cells
expressing gp9-T7 or gp9-HA showed only a low signal in
the corresponding supernatants. This verifies that the plas-
mid encoded gp9 proteins with the epitope tags were effi-
ciently assembled onto the phage particles.
T h ee x p o s u r eo ft h ea n t i g e n i ce p i t o p e so nt h ep h a g e
particles was then tested with immunogold (Figure 7).
First, phage was incubated with the respective serum,
then with protein A coupled immunogold particles (20
nm) and applied to coated copper grids. After staining
with 5% phosphotungstic acid (pH 7) the phage particles
were inspected. Several gold nanoparticles were bound
to the tip of individual phages either with the T7 tag
(panel A) the double T7 tag (panel B), or the double
HA tag (panel C, D, E). The parental M13am9p h a g e ,
used as a control showed no binding of the gold nano-
particles to the tip (panel F). In contrast, for both com-
plemented phage particles we found that about 30% of
the gold nanoparticles were bound to phage particles
and about 20% of the phage had a gold nanoparticle
bound at the tip. Taken together, the analysis shows
that the modified gp9 proteins are well exposed and
accessible to antibodies.
Discussion
The minor coat protein gp9 of the filamentous phage
M13 is exposed from the phage particle and can be
modified with short peptides. Here we have shown that
peptides of 17, 18, 32 and 36 amino acid residues can
be incorporated into the amino-terminal region of the
protein without interfering with membrane insertion
and assembly of the phage. The epitopes of these pep-
tides are accessible by antibodies and allow binding of
gold nanoparticles that can be visualised by electron
microscopy. This implicates that gp9 could be used for
the phage display methodology allowing a combination
with the well-established display of modified gp3. Pre-
vious experiments have shown that gp9 of the closely
related fd phage is localised at the distal end, together
with gp7 [3]. In that study, it was also shown, that the
gp9 protein is exposed to the surface in contrast to gp7.
However, a fusion with glutathione-S-transferase (GST)
did not support phage production suggesting that mem-
brane insertion or phage assembly is inhibited. Since
GST is a folded structure of about 35 kDa we tested
smaller fusion proteins that may be tolerated for mem-
brane insertion and phage assembly. By introducing
short antigenic sequences between the amino acid resi-
dues 2 and 3 of gp9 on a plasmid membrane insertion
and phage assembly was followed. Also, longer fusions
consisting of 32 and 36 additional residues that code for
two tandem tags were constructed. Intriguingly, all gp9
fusion proteins complement an amber-9 phage infection
and lead to progeny production up to wild-type levels.
When the phage progeny particles were analysed for the
presentation of their antigenic epitopes we observed by
dot-blot analysis (Figure 6) and immunogold labelling
(Figure 7) a clearly positive response. We conclude that
the amino-terminal end of gp9 is capable to accept
modifications and provides a new possibility for phage
display.
The extended amino-terminal region with an antigenic
tag allowed the investigation of the membrane insertion
of gp9 in detail. Previously, it had been shown by FTIR
spectroscopy that the membrane-inserted protein has a
high a-helical conformation and adopts a transmem-
brane conformation [11]. In a short pulse, the
Į gp8     Į T7     ĮHA pfu/mL
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Figure 6 Presentation of the antigenic tags on gp9 of phage
particles. (A) M13 phage (panel A) was applied onto nitrocellulose
membrane and incubated with antibody to gp8, T7 tag and HA tag,
respectively, at the indicated concentrations. To visualise the phage
a peroxidase-linked secondary antibody was applied and analysed
by chemoluminescence. (B) M13am9 phage grown in E. coli K38
cells bearing a plasmid encoding gp9-T7 or gp9-DT7, respectively,
were incubated with antibody to T7 and treated as described
above. (C) M13am9 phage propagated in E. coli K38 cells bearing a
plasmid encoding gp9-HA or gp9-DHA, respectively, were incubated
with antibody to HA and treated as described above. For controls
(Ctr), uninfected cultures were tested under identical conditions.
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Page 5 of 9synthesised gp9 was radioactively labelled and analysed
for membrane insertion by protease added to the out-
side of the membrane (Figure 5). Indeed, the protease
removed the antigenic tag at the N-terminus of gp9,
whereas the cytoplasmic GroEL protein was protected
from proteolysis. When the same experiment was per-
formed in cells that were depleted for YidC, gp9 was
not digested suggesting that it was not inserted into the
AB
C D C D
E F
Figure 7 Binding of conjugated gold to M13 phage with modified gp9.M 1 3 am9 phage propagated in E. coli K38 cells bearing a plasmid
encoding gp9-DT7 or gp9-DHA, respectively, was tested for the presentation of the tag at the tip of the phage particles. The phage was
incubated with the respective antibody and to protein A coupled immunogold particles (20 nm). M13am9-gp9-DT7 phage (A, B) and M13am9-
gp9-DHA phage (C - E) were applied onto carbon coated grids, stained with 5% phosphotungstic acid and analysed by electron microscopy. For
a control, M13 phage was applied (F). The scale bars correspond to 500 nm.
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Page 6 of 9membrane under these conditions. We conclude, that
gp9 uses the YidC-only pathway for insertion similar to
gp8 [4,5]. In contrast to our in vivo experiments, earlier
in vitro data with artificial liposomes consisting of
D O P Ca n dD O P Gh a ds u g g e s t e dt h a tt h eg p 9p r o t e i n
inserts sponanteously into the membrane [12].
Very recently, similar gp9 variants to our gp9 fusion
proteins were described that allowed a display on the
phage [10]. In contrast to our work, a phagemid system
was used and the N-terminus of gp9 fusion protein had
a pelB signal sequence attached. This likely changes the
route of membrane insertion to the Sec-translocase and
allows the translocation of large N-terminal domains
across the cytoplasmic membrane. Compared to the
phagemid system used in previous reports [10,13-15],
we present a new method of gp9 phage display which
allows a polyvalent phage display without the need of an
N-terminal signal sequence and helper phage infection.
In our system the only gp9 copy available is the modi-
fied gp9 protein on a plasmid when amber 9 phage was
used. Therefore, all gp9 proteins on the phage particle
possess the modified N-terminus. Further, our system
allows to clearly determine the extend of interference of
the modified protein with the propagation cycle of the
phage. When no interference is observed and the gp9
fusion protein can substitute for the wild-type, amber 9
phage can be used to generate modified phage particles
without a modification of the phage genome. This appli-
cation might be useful for systems that are sensitive to
genetically modified organisms according to (GMO)-
rules.
Conclusions
Bacteriophage M13 is suitable for phage display not only
with a modified gp3 but also with a modified gp9 which
is a minor coat protein at the phage tip. The modified
gp9 protein can be supplied in trans from a plasmid
and fully complements an amber 9 phage mutant. The
modified phage tip is very well accessible to specific
antibodies.
Methods
Phage, plasmid and bacterial strains
M13 phage was from our lab collection [16]. M13am9
with an amber mutation in the second codon of gIX
was constructed by site-directed mutagenesis [17]. For
the construction of gp9-T7, gp9-DT7, gp9-HA and gp9-
DHA RF-DNA of M13mp19 served as template for PCR
amplification. The PCR amplified gIX was subcloned
into pMS119 [18] and an unique MunI restriction site
was introduced by QuikChange
TM in vitro mutagenesis
between the codons 2 and 3. Into this site RF-DNA of
M13mp19 served as template for the amplification of
gIX by PCR. The gIX fragment was subcloned into
pMS119, DNA fragments encoding the T7 and HA tag
sequences were introduced by ligation, resulting in
pMS-g9-T7 and pMS-g9-HA. Also, longer epitopes were
introduced to construct pMS-g9-DT7 and pMS-g9-
DHA, respectively. For protein expression and comple-
mentation experiments E. coli K38 (HfrC T2R relA1 pit-
10 spoT1 tonA22 ompF627 phoA4 l
-) [19] was trans-
formed as a non-suppressor strain. E. coli K37 (HfrC
supD32 relA1 pit-10 spoT1 tonA22 ompF627 phoA4
T2R l
-) [19,20] was used as a suppressor strain and E.
coli JS7131 (MC1060 ΔyidC attB::R6Kori ParaBADyidC
+
Spec
r) as a depletion strain of the membrane insertase
YidC [4].
Complementation test of phage expressing modified gp9
proteins
On agar plates 4 mL melted LB top agar (47°C) contain-
ing 1 mM IPTG was mixed with 500 μLo faf r e s hE.
coli K38 overnight culture bearing either pMS-g9/7
pMS-g9-T7, pMS-g9-DT7, pMS-g9-HA or pMS-g9-
DHA. After solidification of the top agar, 10 μLo fa
phage suspension was applied on top of the agar from
serial dilutions of a phage stock. Plaque formation was
observed after incubation at 37°C overnight.
Expression of the modified gp9 proteins
2m Lc u l t u r e so fE. coli K38 bearing plasmids encoding a
respective gp9 variant were grown at 37°C to the early
exponential phase in M9 minimal medium. Protein
expression was induced by adding 1 mM IPTG and 10
min later the newly synthesised proteins were pulse-
labelled for 10 min with 20 μCi
35S-methionine. To
remove the non-incorporated
35S-methionine the total
bacterial proteins were precipitated with 12% TCA on ice
overnight, washed with cold acetone and resuspended in
10 mM Tris/HCl 2% SDS, pH 8.0. The samples were
immunoprecipitated with antiserum to the T7 tag (Nova-
gen) or to the HA tag (Roche), respectively, and analysed
by SDS tricine PAGE and phosphorimaging.
Membrane insertion of gp9
To test the membrane insertion of gp9, E. coli K38 bear-
ing pMS-g9-T7 was grown to the early exponential
phase in M9 minimal medium. Cells were induced for
10 min with 1 mM IPTG and labelled with
35S-methio-
nine for 10 min. To generate spheroplasts, the cells
were centrifuged at 12 000 g for 3 min and resuspended
in 500 μL of ice-cold spheroplast buffer (40% w/v
sucrose, 33 mM Tris/HCl, pH 8.0). Lysozyme (5 μg/mL,
final concentration) and 1 mM EDTA were added for
15 min. Aliquots of the spheroplast suspension were
incubated on ice for 1 h either in the presence or
absence of 0.5 mg/mL proteinase K. The samples were
precipitated with 12% TCA, washed with cold acetone
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and immunoprecipitated with antibodies against T7,
OmpA (a periplasmic control), or GroEL (a cytoplasmic
control). Samples were analysed by SDS tricine PAGE
and phosphorimaging.
In vivo assay of YidC dependent membrane insertion
To test the requirement of YidC for the membrane
insertion of gp9-T7, the YidC depletion strain E. coli
JS7131 bearing pMS-g9-T7 was grown to the early
exponential phase in LB with 0.2% arabinose. After
back-dilution, the cells were grown in M9 minimal med-
ium with either 0.2% arabinose (YidC
+)o r0 . 2 %g l u c o s e
(YidC
-) for 2 h. To induce expression of gp9-T7, 1 mM
IPTG was added and after 10 min the cells were pulse-
labelled with
35S-methionine for 10 min and then con-
verted to spheroplasts by lysozyme treatment as
described above. Samples were immunoprecipitated with
antibodies to T7, OmpA (a periplasmic control), or
GroEL (a cytoplasmic control). For testing the YidC
depletion, samples of the cultures were drawn and preci-
pitated with TCA (12%, final concentration), washed
with cold acetone, resuspended in 10 mM Tris/HCl, 2%
SDS, pH 8.0 and analysed by SDS/PAGE and Western
blot using YidC antiserum.
M13am9 phage presenting gp9 variant proteins
50 mL cultures of E. coli K38 cells harbouring either
pMSg9-T7, pMSg9-DT7, pMSg9-HA or pMSg9-DHA
were grown at 37°C in LB-medium to a density of 2 ×
10
8 cells/mL. The expression of the gp9 variant proteins
was induced by adding 1 mM IPTG and the cells were
infected with M13am9 at m.o.i 10. Adsorption of the
phage was allowed for 5 min at room temperature with-
out shaking. Subsequently, the infected cells were sha-
ken overnight at 37°C. The phage was harvested from
the supernatant after removing the cells by centrifuga-
tion. Then, the phage titer was determined by serial
dilutions on E. coli K37. Every dilution was plated three
times on LB agar plates to control variations in plating
and pipetting. The agar plates were incubated at 37°C
overnight and the plaques were counted and averaged
for each dilution step.
Dot-blot analysis
For detection of the plasmid-encoded variants on the
phage via dot-blot, serial dilutions of the above
described phage stocks were prepared resulting in equal
amounts of phage particles/400 μL for every variant. 400
μL of each suspension was adsorbed on a nitrocellulose
membrane (Hybond ECL Nitrocellulose, Amersham) via
dot-blot equipment (MiniFold
®, Schleicher & Schuell)
and treated overnight with blocking solution (1x Tris-
buffered saline (TBS) pH 8, 5% non-fat dry milk w/v).
The blot was washed three times with 1x TBS and incu-
bated with antiserum to M13 gp8, to T7 or to HA tag,
respectively. The presence of gp9 variants was analysed
with a secondary peroxidase-coupled antibody by
chemoluminescence.
Immunogold labelling of M13gp9 variant phage for TEM
For testing the exposure of an antigenic epitope 50 μL
of each phage stock solution (about 10
11 phage/mL) of
M13gp9-DT7 and M13gp9-DHA was incubated with 1
× TBS containing 0.1% BSA for 30 min to avoid
unspecific binding of the primary antibody to the sam-
ple. Each sample was then incubated with the respec-
tive serum (diluted 1:20 in 1x TBS) for 1 h. Then,
protein A coupled immunogold particles (Protein A -
20 nm colloidal gold, Sigma-Aldrich) was added 1:20
in 1x TBS for 1 h. After immunogold labelling, 10 μL
of the phage stock solution was adsorbed on carbon-
coated copper grids (Athene 200, Plano, Wetzlar/Ger-
many) that had been glow discharged shortly before
use [21]. The suspensions were allowed to adsorb for 5
m i n ,u n b o u n dm a t e r i a lw a sr e m o v e db yt o u c h i n gt h e
grid to filter paper. The grid was then washed by
touching the surface of a drop of distilled water for 2
sec. The excess water was removed by touching the
grid to filter paper. A drop (5 μL) of 5% phospho-
tungstic acid (pH 7) was then applied to the grid and
after 30 sec the excess stain was removed by touching
the grid to a drop (50 μL) of ddH20f o r2s e c .T h e
excess liquid was drawn off with filter paper. The grid
was dried at room temperature and examined by elec-
tron microscopy.
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